Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
作者信息
Reynolds J L, Whitlock R M
出版信息
Br Heart J. 1972 Mar;34(3):252-9. doi: 10.1136/hrt.34.3.252.
Abstract
摘要
相似文献
1
Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.β-肾上腺素能受体阻滞剂对心肌梗死后发病一年治疗效果的影响。
Br Heart J. 1972 Mar;34(3):252-9. doi: 10.1136/hrt.34.3.252.
2
Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.心绞痛的预防性治疗。阿普洛尔与戊四硝酯的双盲交叉对照比较。
Br Med J. 1970 Jan 24;1(5690):203-6. doi: 10.1136/bmj.1.5690.203.
3
Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.心得舒治疗心绞痛。一项关于新型β-肾上腺素能阻滞剂的临床与测力计研究。
Ann Clin Res. 1969 May;1(1):13-21.
4
Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease.阿普洛尔对β肾上腺素能阻滞的循环反应。对慢性心脏病患者的研究。
Am J Cardiol. 1972 Jan;29(1):26-32. doi: 10.1016/0002-9149(72)90411-0.
5
Use of alprenolol in acute cardiac arrhythmias.阿普洛尔在急性心律失常中的应用。
Am J Cardiol. 1972 Jul 11;30(1):77-81. doi: 10.1016/0002-9149(72)90129-4.
6
Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
J Clin Pharmacol J New Drugs. 1970 Jan-Feb;10(1):37-49.
7
[The anti-arrythmic affect of a new beta-adrenergic blocking agent (H 56-28, Aptin). A study with the aid of continuing ECG-monitoring].
Ugeskr Laeger. 1968 Jul 11;130(29):1171-8.
8
Alprenolol in resuscitation.阿普洛尔在复苏中的应用。
Br Med J. 1971 Dec 18;4(5789):723. doi: 10.1136/bmj.4.5789.723.
9
A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study.
Br J Clin Pract. 1972 May;26(5):217-22.
10
Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agent.新型β-肾上腺素能阻滞剂阿普洛尔对持续性室性早搏的控制作用
Am Heart J. 1969 May;77(5):598-602. doi: 10.1016/0002-8703(69)90543-2.
引用本文的文献
1
Beta-blockers for suspected or diagnosed acute myocardial infarction.用于疑似或确诊急性心肌梗死的β受体阻滞剂。
Cochrane Database Syst Rev. 2019 Dec 17;12(12):CD012484. doi: 10.1002/14651858.CD012484.pub2.
2
Systematic reviews in context: highlighting systematic reviews relevant to Africa in the Pan African Medical Journal.背景下的系统评价：突出《泛非医学杂志》中与非洲相关的系统评价。
Pan Afr Med J. 2016 Jun 30;24:180. doi: 10.11604/pamj.2016.24.180.10100. eCollection 2016.
3
Metoprolol treatment for two years after coronary bypass grafting: effects on exercise capacity and signs of myocardial ischaemia.冠状动脉搭桥术后美托洛尔治疗两年：对运动能力和心肌缺血体征的影响。
Br Heart J. 1995 Sep;74(3):235-41. doi: 10.1136/hrt.74.3.235.
4
Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.在英国、意大利和南斯拉夫的49家医院进行的普萘洛尔心肌梗死后多中心试验。
Br Heart J. 1980 Jul;44(1):96-100. doi: 10.1136/hrt.44.1.96.
5
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.心肌梗死后使用普萘洛尔进行一年治疗：挪威多中心试验的初步报告。
Br Med J (Clin Res Ed). 1982 Jan 16;284(6310):155-60. doi: 10.1136/bmj.284.6310.155.
6
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.心肌梗死后使用噻吗洛尔治疗的患者中心脏大小对死亡率和再梗死的影响。
Br Heart J. 1983 Aug;50(2):135-9. doi: 10.1136/hrt.50.2.135.
7
Secondary prevention of myocardial infarction: an uncertain feeling.心肌梗死的二级预防：一种不确定的感觉。
J R Coll Gen Pract. 1982 Nov;32(244):651-3.
8
Beta-blockade after myocardial infarction--a statistical view.心肌梗死后的β受体阻滞剂治疗——统计学视角
Br J Clin Pharmacol. 1982;14 Suppl 1(Suppl 1):15S-21S. doi: 10.1111/j.1365-2125.1982.tb02055.x.
9
Secondary prevention in survivors of myocardial infarction. Joint Recommendations by the International Society and Federation of Cardiology, Scientific Councils on Arteriosclerosis, Epidemiology and Prevention, and Rehabilitation.心肌梗死幸存者的二级预防。国际心脏病学会和联合会、动脉硬化科学委员会、流行病学与预防科学委员会以及康复科学委员会联合推荐意见
Br Med J (Clin Res Ed). 1981 Mar 14;282(6267):894-6. doi: 10.1136/bmj.282.6267.894.
10
Calcium antagonists in secondary prevention after myocardial infarction.心肌梗死后二级预防中的钙拮抗剂
Drugs. 1991;42 Suppl 2:54-60. doi: 10.2165/00003495-199100422-00009.
本文引用的文献
1
Clinical aspects of coronary heart disease; an analysis of 100 cases in patients 23 to 40 years of age with myocardial infarction.冠心病的临床情况；对23至40岁心肌梗死患者100例的分析。
J Am Med Assoc. 1951 Aug 4;146(14):1291-5. doi: 10.1001/jama.1951.03670140017005.
2
CLINICAL EXPERIENCE WITH RADIOLOGICAL DETERMINATION OF HEART VOLUME.心脏容积的放射学测定临床经验
Br Heart J. 1963 Sep;25(5):575-82. doi: 10.1136/hrt.25.5.575.
3
Effect of propranolol on systemic and coronary hemodynamics at rest and during simulated exercise.
Circ Res. 1966 Sep;19(3):520-7. doi: 10.1161/01.res.19.3.520.
4
Propranolol and angina pectoris.普萘洛尔与心绞痛
Am J Cardiol. 1966 Sep;18(3):345-53. doi: 10.1016/0002-9149(66)90052-x.
5
Cardiovascular pharmacology of propranolol in man.普萘洛尔在人体中的心血管药理学
Circulation. 1969 Oct;40(4):501-11. doi: 10.1161/01.cir.40.4.501.
6
Blood pressure; its relation to atherosclerotic disease of the coronaries.血压；其与冠状动脉粥样硬化疾病的关系。
Bull N Y Acad Med. 1968 Aug;44(8):968-84.
7
Trial of propranolol in acute myocardial infarction.普萘洛尔治疗急性心肌梗死的试验。
Br Med J. 1968 May 18;2(5602):398-400. doi: 10.1136/bmj.2.5602.398.
8
Alprenolol in acute myocardial infarction: Double-blind trial.心得舒用于急性心肌梗死：双盲试验。
N Z Med J. 1970 Mar;71(454):135-8.
9
Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.心得舒治疗心绞痛。一项关于新型β-肾上腺素能阻滞剂的临床与测力计研究。
Ann Clin Res. 1969 May;1(1):13-21.
10
Myocardial and haemodynamic effects of the beta-adrenoceptor blocking drug alprenolol (H56/28) in anaesthetized cats.β-肾上腺素能受体阻断药阿普洛尔（H56/28）对麻醉猫的心肌及血流动力学影响
Br J Pharmacol. 1969 Oct;37(2):357-66.
Zotero 插件